These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 18535871)

  • 1. The potential use of ephedrine in Lambert-Eaton myasthenic syndrome : clinical and electrophysiological evaluation.
    Cereda C; Kuntzer T
    J Neurol; 2008 Aug; 255(8):1259-60. PubMed ID: 18535871
    [No Abstract]   [Full Text] [Related]  

  • 2. Lambert-Eaton myasthenic syndrome: evaluation of movement performance following drug therapy.
    Cooke JD; Hefter H; Brown SH; Toyka KV; Freund HJ
    Electromyogr Clin Neurophysiol; 1994 Mar; 34(2):87-93. PubMed ID: 8187683
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of 3,4-diaminopyridine on the time course of decay of compound muscle action potential augmentation in the Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J; Mills KR
    Muscle Nerve; 1998 Sep; 21(9):1196-8. PubMed ID: 9703446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term follow-up in infantile-onset lambert-eaton myasthenic syndrome.
    Portaro S; Parisi D; Polizzi A; Ruggieri M; Andreetta F; Bernasconi P; Toscano A; Rodolico C
    J Child Neurol; 2014 Sep; 29(9):NP58-61. PubMed ID: 24114606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-exercise exhaustion in Lambert-Eaton myasthenic syndrome.
    Oh SJ; Hatanaka Y; Ito E; Nagai T
    Clin Neurophysiol; 2014 Feb; 125(2):411-4. PubMed ID: 24128793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low rate repetitive nerve stimulation in Lambert-Eaton myasthenic syndrome: peculiar characteristics of decremental pattern from a single-centre experience.
    Luigetti M; Modoni A; Lo Monaco M
    Clin Neurophysiol; 2013 Apr; 124(4):825-6. PubMed ID: 23036181
    [No Abstract]   [Full Text] [Related]  

  • 7. Single-fiber electromyography improvement with 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome.
    Kim DS; Claussen GC; Oh SJ
    Muscle Nerve; 1998 Aug; 21(8):1107-8. PubMed ID: 9655139
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiological differences in seropositive and seronegative Lambert-Eaton myasthenic syndrome.
    Oh SJ; Hatanaka Y; Claussen GC; Sher E
    Muscle Nerve; 2007 Feb; 35(2):178-83. PubMed ID: 17058271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing Features of the Repetitive Nerve Stimulation Test Between Lambert-Eaton Myasthenic Syndrome and Myasthenia Gravis, 50-Year Reappraisal.
    Oh SJ
    J Clin Neuromuscul Dis; 2017 Dec; 19(2):66-75. PubMed ID: 29189551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological diagnostic criteria of Lambert-Eaton myasthenic syndrome.
    Oh SJ; Kurokawa K; Claussen GC; Ryan HF
    Muscle Nerve; 2005 Oct; 32(4):515-20. PubMed ID: 16003742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestation of Lambert-Eaton myasthenic syndrome during last trimester of pregnancy.
    Bayrak AO; Sandikci U; Yon SK; Onar MK
    Int J Neurosci; 2010 Jun; 120(6):439-41. PubMed ID: 20504215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological and clinical correlations in the Lambert-Eaton myasthenic syndrome.
    Oh SJ; Kim DE; Kuruoglu R; Brooks J; Claussen G
    Muscle Nerve; 1996 Jul; 19(7):903-6. PubMed ID: 8965847
    [No Abstract]   [Full Text] [Related]  

  • 13. Ephedrine in the treatment of congenital myasthenic syndrome.
    Felice KJ; Relva GM
    Muscle Nerve; 1996 Jun; 19(6):799-800. PubMed ID: 8609943
    [No Abstract]   [Full Text] [Related]  

  • 14. Acetylcholine receptor antibodies in the Lambert-Eaton myasthenic syndrome.
    Katz JS; Wolfe GI; Bryan WW; Tintner R; Barohn RJ
    Neurology; 1998 Feb; 50(2):470-5. PubMed ID: 9484374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article.
    Lorenzoni PJ; Kay CSK; Werneck LC; Scola RH
    Arq Neuropsiquiatr; 2018 Feb; 76(2):124-126. PubMed ID: 29489969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome.
    McEvoy KM; Windebank AJ; Daube JR; Low PA
    N Engl J Med; 1989 Dec; 321(23):1567-71. PubMed ID: 2555713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.
    Lorenzoni PJ; Scola RH; Lang B; Kay CS; Teive HA; Kowacs PA; Werneck LC
    J Neurol Sci; 2008 Jul; 270(1-2):194-6. PubMed ID: 18374949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term observation of incremental response and antibodies to voltage-gated calcium channels in patients with Lambert-Eaton myasthenic syndrome: two case reports.
    Schneider I; Kornhuber ME; Hanisch F
    J Med Case Rep; 2015 Mar; 9():59. PubMed ID: 25885033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lambert-Eaton myasthenic syndrome in children.
    Tsao CY; Mendell JR; Friemer ML; Kissel JT
    J Child Neurol; 2002 Jan; 17(1):74-6. PubMed ID: 11913581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-fiber EMG and clinical correlation in Lambert-Eaton myasthenic syndrome.
    Oh SJ; Ohira M
    Muscle Nerve; 2013 May; 47(5):664-7. PubMed ID: 23505075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.